Search hospitals > Nevada > Las Vegas
GenesisCare USA - Las Vegas
Claim this profileLas Vegas, Nevada 89109
Global Leader in Skin Cancer
Global Leader in Stomach Cancer
Conducts research for Uterine Tumors
Conducts research for Cancer
Conducts research for Lung Cancer
116 reported clinical trials
2 medical researchers
Summary
GenesisCare USA - Las Vegas is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Stomach Cancer, Uterine Tumors, Cancer, Lung Cancer and other specialties. GenesisCare USA - Las Vegas is involved with conducting 116 clinical trials across 309 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Stomach Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
158 reported clinical trials
235 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Uterine Tumors
Expert in T-Lymphoblastic Leukemia/Lymphoma
55 reported clinical trials
111 drugs studied
Clinical Trials running at GenesisCare USA - Las Vegas
Breast Cancer
Bladder Cancer
Lung Cancer
Skin Cancer
Bladder Carcinoma
Stomach Cancer
Kidney Cancer
Esophageal Adenocarcinoma
Prostate Cancer
Breast cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at GenesisCare USA - Las Vegas?
GenesisCare USA - Las Vegas is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Stomach Cancer, Uterine Tumors, Cancer, Lung Cancer and other specialties. GenesisCare USA - Las Vegas is involved with conducting 116 clinical trials across 309 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.